ALDH1A1 and neoplasm: ALDH1 activity was significantly reduced in MDA-MB 231 cells treated with siRNA-SMAD5 (Figure 6D), corroborating the findings that SMAD5 expression is required to promote tumor stemness and chemoresistance.